CHOKSI LABORATORIES LTD.
Latest filings
- Company clarifies delay in EGM proceedings submission; preferential warrants issue · Compliance
- Shareholders reject proposed preferential issue of convertible warrants · Fund Raising
- EGM voting results: Preferential warrant issue to promoters rejected · Board & Shareholder Meetings
Snapshot
What the business is, and whether it's a good one at a fair price.
Provides analytical testing and calibration services within the Indian healthcare sector, with operations based out of Indore. The cost structure is heavily employee-driven at 40.5% of revenue, with depreciation at 15.4% and materials at just 7.5% — a shape consistent with a people-and-equipment-intensive service model. Other operating expenses made up 25.7% of revenue, and capital expenditure ran at 16.5% of revenue. The business is family-promoted, with members of the founding family holding the Managing Director and Whole Time Director positions, and is listed on BSE. No segment-level revenue split is disclosed in the available filings. The company recorded an exceptional gain from the sale of an office flat during FY26.
Scorecard
Measured from the filed financials, judged against its Healthcare Service Provider peers · as of FY26 — not investment advice
Strengths
Concerns
Charts
How has the market priced it — with filings on the timeline?
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from CHOKSI LABORATORIES LTD.'s filed financials and exchange disclosures
What does CHOKSI LABORATORIES LTD. do?
CHOKSI LABORATORIES LTD. is a Healthcare Services company listed on BSE.
Is CHOKSI LABORATORIES LTD. profitable?
Yes. Over the trailing twelve months CHOKSI LABORATORIES LTD. reported a net profit of ₹1.96 Cr on revenue of ₹46 Cr.
Does CHOKSI LABORATORIES LTD. pay a dividend?
Not in the latest reported year — CHOKSI LABORATORIES LTD.'s dividend payout for FY26 was nil.
Is CHOKSI LABORATORIES LTD. debt-free?
No. It reported borrowings of ₹30 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹30 Cr after cash. Debt stands at 1.18× equity. That is higher than 95% of its 23 Healthcare Service Provider peers.
Is CHOKSI LABORATORIES LTD. expensive compared with its peers?
On trailing P/E, CHOKSI LABORATORIES LTD. ranks 21 of 25 in Healthcare Service Provider — cheaper than 17% of them, against an industry median of 23.4×. This is a position, not a valuation judgement.
How much does the CHOKSI LABORATORIES LTD. share price move in a day?
On a typical session CHOKSI LABORATORIES LTD. moves 2.39% — that is the median absolute close-to-close move across its last 266 trading days. MarketPing measures each filing's price reaction against it.
Where can I track CHOKSI LABORATORIES LTD.'s announcements?
Every NSE and BSE filing by CHOKSI LABORATORIES LTD. appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.